Search research articles
Contact Us
Filters
Showing results (61-70 of 109) with videos related to
Page
of 11
Sort By:
Frontiers in Oncology
|
May 26, 2023
Enhancing gastric cancer conventional chemotherapy effects by triple angiokinase inhibitor nintedanib in preclinical models
Niranjan Awasthi, Margaret A Schwarz, Quinn Kaurich, et al.
Surgery Open Science
|
June 5, 2023
Low incisional hernia incidence using a large-bite, low-tension technique for celiotomy closure
Joy Sarkar, Michael J Minarich, Levi Y Smucker, et al.
The American Journal of Surgical Pathology
|
February 24, 2005
Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2
Peiguo G Chu, Roderich E Schwarz, Sean K Lau, et al.
Cancer Biology & Therapy
|
March 10, 2010
Antitumor effects of EMAP II against pancreatic cancer through inhibition of fibronectin-dependent proliferation
Roderich E Schwarz, Niranjan Awasthi, Srivani Konduri, et al.
Cancer Research
|
August 4, 2004
Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1
Gayathri Subramanian, Roderich E Schwarz, Linda Higgins, et al.
Molecular Cancer Therapeutics
|
March 11, 2014
Enhancement of nab-paclitaxel antitumor activity through addition of multitargeting antiangiogenic agents in experimental pancreatic cancer
Niranjan Awasthi, Changhua Zhang, Anna M Schwarz, et al.
World Journal of Oncology
|
November 18, 2017
Clinical Evidence: Metastases can Metastasize
Gregory A Stanley, Jyoti P Balani, David S Miller, et al.
Biochemical Pharmacology
|
September 18, 2002
Chemosensitization by fibroblast growth factor-2 is not dependent upon proliferation, S-phase accumulation, or p53 status
Aaron B Coleman, Marianne Z Metz, Cécile A Donohue, et al.
American Journal of Clinical Oncology
|
June 1, 2002
Long-term survival after radical operations for cancer treatment-induced sarcomas: how two survivors invite reflection on oncologic treatment concepts
Roderich E Schwarz, Georg Hillebrand, Elizabeth A Peralta, et al.
Oncotarget
|
April 30, 2016
Augmentation of response to nab-paclitaxel by inhibition of insulin-like growth factor (IGF) signaling in preclinical pancreatic cancer models
Niranjan Awasthi, Emily Scire, Sheena Monahan, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 109) with videos related to
Sort By:
Page
of 11
Frontiers in Oncology
|
May 26, 2023
Enhancing gastric cancer conventional chemotherapy effects by triple angiokinase inhibitor nintedanib in preclinical models
Niranjan Awasthi, Margaret A Schwarz, Quinn Kaurich, et al.
Surgery Open Science
|
June 5, 2023
Low incisional hernia incidence using a large-bite, low-tension technique for celiotomy closure
Joy Sarkar, Michael J Minarich, Levi Y Smucker, et al.
The American Journal of Surgical Pathology
|
February 24, 2005
Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2
Peiguo G Chu, Roderich E Schwarz, Sean K Lau, et al.
Cancer Biology & Therapy
|
March 10, 2010
Antitumor effects of EMAP II against pancreatic cancer through inhibition of fibronectin-dependent proliferation
Roderich E Schwarz, Niranjan Awasthi, Srivani Konduri, et al.
Cancer Research
|
August 4, 2004
Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1
Gayathri Subramanian, Roderich E Schwarz, Linda Higgins, et al.
Molecular Cancer Therapeutics
|
March 11, 2014
Enhancement of nab-paclitaxel antitumor activity through addition of multitargeting antiangiogenic agents in experimental pancreatic cancer
Niranjan Awasthi, Changhua Zhang, Anna M Schwarz, et al.
World Journal of Oncology
|
November 18, 2017
Clinical Evidence: Metastases can Metastasize
Gregory A Stanley, Jyoti P Balani, David S Miller, et al.
Biochemical Pharmacology
|
September 18, 2002
Chemosensitization by fibroblast growth factor-2 is not dependent upon proliferation, S-phase accumulation, or p53 status
Aaron B Coleman, Marianne Z Metz, Cécile A Donohue, et al.
American Journal of Clinical Oncology
|
June 1, 2002
Long-term survival after radical operations for cancer treatment-induced sarcomas: how two survivors invite reflection on oncologic treatment concepts
Roderich E Schwarz, Georg Hillebrand, Elizabeth A Peralta, et al.
Oncotarget
|
April 30, 2016
Augmentation of response to nab-paclitaxel by inhibition of insulin-like growth factor (IGF) signaling in preclinical pancreatic cancer models
Niranjan Awasthi, Emily Scire, Sheena Monahan, et al.
Page
of 11